AliveCor is a Mountain View, California digital health company that pioneered the personal, FDA-cleared electrocardiogram (ECG). Its Kardia line of pocket-sized devices lets people record a medical-grade ECG on a smartphone in about 30 seconds, while AI algorithms screen for atrial fibrillation and other arrhythmias. Combining hardware, a subscription care service, and enterprise cardiology programs, AliveCor has recorded well over 160 million ECGs for millions of users and works with clinicians, employers, health systems, and pharmaceutical researchers.
Apollon is a Korean-American medtech company building MOGLU, a needle-free continuous glucose monitor that reads blood sugar through the skin using Raman spectroscopy instead of a subcutaneous filament. Founded in Seoul in 2021 by Aram Hong and researchers tied to MIT and Asan Medical Center, the company is developing a compact wearable that reported accuracy comparable to leading CGMs in early MIT clinical testing, has been granted FDA Breakthrough Device designation, and won a 2025 CES Innovation Award.
Aram Hong is the CEO and co-founder of Apollon, a Seoul-born, Cambridge-based medtech company building MOGLU, a needle-free continuous glucose monitor powered by Raman spectroscopy. A former EY advisor and Genoplan executive who moved his family from Seoul to Boston to scale the company alongside MIT researchers, Hong has turned a laser-and-optics idea into a CES 2025 Innovation Award honoree that, in peer-reviewed clinical testing, matched the accuracy of leading needle-based sensors from Abbott and Dexcom.